|
|
Blood, 1 February 2004, Vol. 103, No. 3, pp. 1030-1032.
Prepublished online as a Blood First Edition Paper on September 22, 2003; DOI 10.1182/blood-2003-04-1216.
 Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
Brief report
Blood plasmacytoid dendritic cell responses to CpG oligodeoxynucleotides are impaired in human newborns
Dominique De Wit,
Véronique Olislagers,
Stanislas Goriely,
Françoise Vermeulen,
Hermann Wagner,
Michel Goldman, and
Fabienne Willems
From the Laboratory of Experimental Immunology, Centre de Recherche Interuniversitaire en Vaccinologie, and FOCIS Center of the Université Libre de Bruxelles, Brussels, Belgium; and the Institute of Medical Microbiology, Immunology and Hygiene, Technische Universität München, Munich, Germany.
Plasmacytoid dendritic cells (pDCs) respond to unmethylated cytosine-phosphate-guanosine (CpG) motifs present in bacterial DNA or unmethylated synthetic oligodeoxynucleotides (CpG). In order to assess the function of pDCs in human newborns, interferon- (IFN-) production induced by CpG 2216 and phenotypic maturation of pDCs in response to CpG 2006 were compared in cord blood and adult blood. We first observed that neonatal pDCs displayed decreased up-regulation of CD80, CD83, CD86, and CD40, whereas HLA-DR and CD54 up-regulation did not differ significantly between adults and neonates. We then found that the production of IFN- in response to CpG was dramatically impaired in cord blood. This neonatal defect was detected both at protein and mRNA levels and was still present in blood of 4-day-old babies. Further experiments on enriched pDCs confirmed that these cells are intrinsically deficient in CpG-induced IFN- production at birth. These findings might be relevant to the increased susceptibility of human newborns to infections as well as to the use of CpG oligodeoxynucleotides as vaccine adjuvants in the neonatal period. (Blood. 2004;103:1030-1032)
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
L. M'Rabet, A. P. Vos, G. Boehm, and J. Garssen
Breast-Feeding and Its Role in Early Development of the Immune System in Infants: Consequences for Health Later in Life
J. Nutr.,
September 1, 2008;
138(9):
1782S - 1790S.
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. E. Walker and D. R. Goldstein
Neonatal B Cells Suppress Innate Toll-Like Receptor Immune Responses and Modulate Alloimmunity
J. Immunol.,
August 1, 2007;
179(3):
1700 - 1710.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. J. C. Miles, M. van der Sande, D. Jeffries, S. Kaye, J. Ismaili, O. Ojuola, M. Sanneh, E. S. Touray, P. Waight, S. Rowland-Jones, et al.
Cytomegalovirus Infection in Gambian Infants Leads to Profound CD8 T-Cell Differentiation
J. Virol.,
June 1, 2007;
81(11):
5766 - 5776.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Aksoy, V. Albarani, M. Nguyen, J.-F. Laes, J.-L. Ruelle, D. De Wit, F. Willems, M. Goldman, and S. Goriely
Interferon regulatory factor 3-dependent responses to lipopolysaccharide are selectively blunted in cord blood cells
Blood,
April 1, 2007;
109(7):
2887 - 2893.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J Bonhoeffer, C-A Siegrist, and P T Heath
Immunisation of premature infants
Arch. Dis. Child.,
November 1, 2006;
91(11):
929 - 935.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Stasiolek, A. Bayas, N. Kruse, A. Wieczarkowiecz, K. V. Toyka, R. Gold, and K. Selmaj
Impaired maturation and altered regulatory function of plasmacytoid dendritic cells in multiple sclerosis
Brain,
May 1, 2006;
129(5):
1293 - 1305.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Pedras-Vasconcelos, D. Goucher, M. Puig, L. H. Tonelli, V. Wang, S. Ito, and D. Verthelyi
CpG oligodeoxynucleotides protect newborn mice from a lethal challenge with the neurotropic tacaribe arenavirus.
J. Immunol.,
April 15, 2006;
176(8):
4940 - 4949.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Vakkila, R. Jaffe, M. Michelow, and M. T. Lotze
Pediatric cancers are infiltrated predominantly by macrophages and contain a paucity of dendritic cells: a major nosologic difference with adult tumors.
Clin. Cancer Res.,
April 1, 2006;
12(7):
2049 - 2054.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Omatsu, T. Iyoda, Y. Kimura, A. Maki, M. Ishimori, N. Toyama-Sorimachi, and K. Inaba
Development of Murine Plasmacytoid Dendritic Cells Defined by Increased Expression of an Inhibitory NK Receptor, Ly49Q
J. Immunol.,
June 1, 2005;
174(11):
6657 - 6662.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. B. Gurney, A. D. Colantonio, B. Blom, H. Spits, and C. H. Uittenbogaart
Endogenous IFN-{alpha} Production by Plasmacytoid Dendritic Cells Exerts an Antiviral Effect on Thymic HIV-1 Infection
J. Immunol.,
December 15, 2004;
173(12):
7269 - 7276.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
